J Cabeza Barrera

Statistics

Publications

Citations

201

H-Index

Active since

1997

Affiliations

Instituto de Investigación Biosanitaria de Granada(Current)

Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research

Universidad de Granada

J Cabeza Barrera is an author at Instituto de Investigación Biosanitaria de Granada specializing in pharmacogenetics, genetics, and autoimmune diseases.

ORCID

Publications per year

1997–2023

Publications

Results of genotype-guided antiplatelet therapy in patients who undergone percutaneous coronary intervention with stent

Jesús Sánchez-Ramos, Cristina Lucía Dávila-Fajardo, Pablo Toledo Frías et al. · International Journal of Cardiology · 2016 · 64 citations

Medicine, Cardiology, Internal Medicine +14

Analysing the In-Use Stability of mRNA-LNP COVID-19 Vaccines Comirnaty™ (Pfizer) and Spikevax™ (Moderna): A Comparative Study of the Particulate

Jesús Hermosilla, Airan Alonso-García, Antonio Salmerón‐García et al. · Vaccines · 2023 · 37 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmaceutical Biotechnology +17

<i>FcGR</i>Genetic Polymorphisms and the Response to Adalimumab in Patients with Rheumatoid Arthritis

Cristina Lucía Dávila-Fajardo, Tahar van der Straaten, R. F. Baak-Pablo et al. · Pharmacogenomics · 2015 · 31 citations

Life Sciences, Genetics, Immunology +17

A New Pharmacogenetic Algorithm to Predict the Most Appropriate Dosage of Acenocoumarol for Stable Anticoagulation in a Mixed Spanish Population

Hoi Y. Tong, Cristina Lucía Dávila-Fajardo, Alberto M. Borobia et al. · PLoS ONE · 2016 · 22 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

IL2/IL21 region polymorphism influences response to rituximab in systemic lupus erythematosus patients

Ana Márquez, Cristina Lucía Dávila-Fajardo, Gema Robledo et al. · Molecular Biology Reports · 2013 · 14 citations

Life Sciences, Genetics, Immunology +12

1–5 of 8